Qube Research & Technologies Ltd - CYTOKINETICS INC ownership

CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 256 filers reported holding CYTOKINETICS INC in Q3 2023. The put-call ratio across all filers is 2.72 and the average weighting 0.2%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of CYTOKINETICS INC
ValueSharesWeighting
Q3 2023$285,998
-90.8%
9,708
-89.8%
0.00%
-90.9%
Q2 2023$3,117,037
-13.6%
95,556
-6.8%
0.01%
-31.2%
Q1 2023$3,606,905
+716.0%
102,498
+728.3%
0.02%
+166.7%
Q3 2021$442,000
+48.3%
12,374
-10.0%
0.01%
+50.0%
Q3 2020$298,000
-47.0%
13,748
-42.3%
0.00%
-50.0%
Q2 2020$562,00023,8390.01%
Other shareholders
CYTOKINETICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 223,382$7,286,7218.83%
Saturn V Capital Management LP 406,225$13,251,0607.35%
Logos Global Management LP 1,650,000$53,823,0007.32%
Finepoint Capital LP 369,093$12,039,8144.16%
GREAT POINT PARTNERS LLC 600,000$19,572,0003.83%
Boxer Capital, LLC 2,100,000$68,5023.18%
PFM Health Sciences, LP 2,399,545$78,273,1583.04%
DAFNA Capital Management LLC 332,734$10,853,7832.97%
Integral Health Asset Management, LLC 650,000$21,203,0002.62%
Sofinnova Investments, Inc. 843,228$27,506,0971.80%
View complete list of CYTOKINETICS INC shareholders